Top

Gepubliceerd in:

19-03-2022

Using Behavioral Science to Address COVID-19 Vaccine Hesitancy Among Cancer Survivors: Communication Strategies and Research Opportunities

Auteurs: Robin C. Vanderpool, Anna Gaysynsky, Wen-Ying Sylvia Chou, Emily S. Tonorezos

Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 1-2/2023

Abstract

Due to cancer survivors’ increased vulnerability to complications from COVID-19, addressing vaccine hesitancy and improving vaccine uptake among this population is a public health priority. However, several factors may complicate efforts to increase vaccine confidence in this population, including the underrepresentation of cancer patients in COVID-19 vaccine trials and distinct recommendations for vaccine administration and timing for certain subgroups of survivors. Evidence suggests vaccine communication efforts targeting survivors could benefit from strategies that consider factors such as social norms, risk perceptions, and trust. However, additional behavioral research is needed to help the clinical and public health community better understand, and more effectively respond to, drivers of vaccine hesitancy among survivors and ensure optimal protection against COVID-19 for this at-risk population. Knowledge generated by this research could also have an impact beyond the current COVID-19 pandemic by informing future vaccination efforts and communication with cancer survivors more broadly.

vorige artikel Understanding the Factors Influencing Health Care Provider Recommendations about Adolescent Vaccines: A Proposed Framework

As defined by the National Cancer Institute, an individual is considered a cancer survivor from the time of

diagnosis through the balance of his or her life. There are many types of survivors, including those living with

cancer and those free of cancer (National Cancer Institute - Office of Cancer Survivorship, 2021).

Agha, M. E., Blake, M., Chilleo, C., Wells, A., & Haidar, G. (2021). Suboptimal response to coronavirus disease 2019 messenger RNA vaccines in patients with hematologic malignancies: a need for vigilance in the postmasking era. Open Forum Infectious Diseases, 8(7), ofab353CrossRefPubMedPubMedCentral

American Society of Clinical Oncology (2021). Inclusion of Individuals with Cancer on COVID-19 Vaccine Trials: A Joint Position Statement from the American Society of Clinical Oncology and Friends of Cancer Research. Retrieved from https://www.asco.org/sites/new-www.asco.org/files/content-files/blog-release/pdf/2021-ASCO-Friends-Vaccine-Trials-Position-Statement.pdf

Brewer, N. T., Chapman, G. B., Gibbons, F. X., Gerrard, M., McCaul, K. D., & Weinstein, N. D. (2007). Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. Health psychology, 26(2), 136CrossRefPubMed

Brewer, N. T., Hall, M. E., Malo, T. L., Gilkey, M. B., Quinn, B., & Lathren, C. (2017). Announcements versus conversations to improve HPV vaccination coverage: a randomized trial.Pediatrics, 139(1)

Britt, E., Hudson, S. M., & Blampied, N. M. (2004). Motivational interviewing in health settings: a review. Patient Education and Counseling, 53(2), 147–155CrossRefPubMed

Centers for Disease Control and Prevention (2021a). COVID Data Tracker - COVID-19 Vaccinations in the United States. Retrieved from https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total

Centers for Disease Control and Prevention (2021b). COVID Data Tracker - Trends in COVID-19 Vaccine Confidence in the US. Retrieved from https://covid.cdc.gov/covid-data-tracker/#vaccine-confidence

Centers for Disease Control and Prevention (2021c). Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States. Retrieved from https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html?ACSTrackingID=USCDC_9_13-DM63868&ACSTrackingLabel=DCPC%20Announcement%3A%20COVID-19%20Vaccine%20Third%20Dose%20for%20Cancer%20Patients&deliveryName=USCDC_9_13-DM63868#considerations-additional-vaccine-dose

Centers for Disease Control and Prevention (2021d). Talking with Patients about COVID-19 Vaccination: An Introduction to Motivational Interviewing for Healthcare Professionals. Retrieved from https://www.cdc.gov/vaccines/covid-19/hcp/engaging-patients.html#:~:text=Motivational%20interviewing%20is%20an%20evidence,with%20their%20values%20and%20needs

Chang, A., Payne, J. B., Allen, P. B., Koff, J. L., Ahmed, R., Flowers, C. R., & Bednarczyk, R. A. (2019). Influenza vaccination documentation rates during the first year after diagnosis of diffuse large B cell lymphoma. Clinical Lymphoma Myeloma and Leukemia, 19(4), 239–243CrossRef

Chou, W. Y. S., Burgdorf, C. E., Gaysynsky, A., & Hunter, C. M. (2020). COVID-19 Vaccination Communication: Applying Behavioral and Social Science to Address Vaccine Hesitancy and Foster Vaccine Confidence. Retrieved from https://obssr.od.nih.gov/sites/obssr/files/inline-files/OBSSR_VaccineWhitePaper_FINAL_508.pdf

Chou, W. Y. S., Gaysynsky, A., & Cappella, J. N. (2020). Where We Go From Here: Health Misinformation on Social Media. American journal of public health, 110(S3), S273–S275. doi:https://doi.org/10.2105/ajph.2020.305905CrossRef

Chou, W. Y. S., & Miller, R. S. (2021). Cancer-Related Misinformation Online: How Bad Is It and What Should Oncologists Do About It? ASCO Daily News. Retrieved from https://dailynews.ascopubs.org/do/https://doi.org/10.1200/ADN.21.200673/full/

Cipolletta, S., Simonato, C., & Faccio, E. (2019). The effectiveness of psychoeducational support groups for women with breast cancer and their caregivers: a mixed methods study. Frontiers in psychology, 10, 288CrossRefPubMedPubMedCentral

Conti, R., Akesson, J., Weiss, E., Sae-Hau, M., Lee, M., Gracia, G., & Metcalfe, R. (2021). COVID-19 vaccine hesitancy among blood cancer patients

Copeland, L., McNamara, R., Kelson, M., & Simpson, S. (2015). Mechanisms of change within motivational interviewing in relation to health behaviors outcomes: a systematic review. Patient Education and Counseling, 98(4), 401–411CrossRefPubMed

Dempsey, A., Kwan, B. M., Wagner, N. M., Pyrzanowski, J., Brewer, S. E., Sevick, C., & Glanz, J. (2020). A values-tailored web-based intervention for new mothers to increase infant vaccine uptake: development and qualitative study. Journal of medical Internet research, 22(3), 98–113

Desai, A., Gainor, J. F., Hegde, A., Schram, A. M., Curigiliano, G., Pal, S., & Grande, E. (2021). COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials. Nature Reviews Clinical Oncology,1–7

Dubé, E., Laberge, C., Guay, M., Bramadat, P., Roy, R., & Bettinger, J. A. (2013). Vaccine hesitancy: an overview. Human vaccines & immunotherapeutics, 9(8), 1763–1773CrossRef

Epstein, R. M., & Street, R. L. (2007). Patient-centered communication in cancer care: promoting healing and reducing suffering

Epton, T., Harris, P. R., Kane, R., van Koningsbruggen, G. M., & Sheeran, P. (2015). The impact of self-affirmation on health-behavior change: A meta-analysis. Health Psychology, 34(3), 187CrossRefPubMed

Fillmore, N. R., La, J., Szalat, R. E., Tuck, D. P., Nguyen, V., Yildirim, C., & Munshi, N. C. (2021). Prevalence and outcome of COVID-19 infection in cancer patients: a national Veterans Affairs study. JNCI: Journal of the National Cancer Institute, 113(6), 691–698CrossRefPubMed

Food and Drug Administration (2021). FDA Approves First COVID-19 Vaccine [Press release]. Retrieved from https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine

Ganatra, S., Dani, S. S., Redd, R., Rieger-Christ, K., Patel, R., Parikh, R., & Brar, S. S. (2020). Outcomes of COVID-19 in Patients With a History of Cancer and Comorbid Cardiovascular Disease. Journal of the National Comprehensive Cancer Network, 1(aop), 1–10

Giese-Davis, J., Bliss‐Isberg, C., Wittenberg, L., White, J., Star, P., Zhong, L., & Spiegel, D. (2016). Peer‐counseling for women newly diagnosed with breast cancer: A randomized community/research collaboration trial. Cancer, 122(15), 2408–2417CrossRefPubMed

Gilkey, M. B., Calo, W. A., Moss, J. L., Shah, P. D., Marciniak, M. W., & Brewer, N. T. (2016). Provider communication and HPV vaccination: the impact of recommendation quality. Vaccine, 34(9), 1187–1192CrossRefPubMedPubMedCentral

Gowda, C., Schaffer, S. E., Kopec, K., Markel, A., & Dempsey, A. F. (2013). A pilot study on the effects of individually tailored education for MMR vaccine-hesitant parents on MMR vaccination intention. Human vaccines & immunotherapeutics, 9(2), 437–445CrossRef

Greenberger, L. M., Saltzman, L. A., Senefeld, J. W., Johnson, P. W., DeGennaro, L. J., & Nichols, G. L. (2021). Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies.Cancer Cell

Guidry, J. P., Carlyle, K. E., Miller, C. A., Ksinan, A. J., Winn, R., Sheppard, V. B., & Fuemmeler, B. F. (2021). Endorsement of COVID-19 related misinformation among cancer survivors.Patient Education and Counseling

Guidry, J. P., Miller, C. A., Ksinan, A. J., Rohan, J. M., Winter, M. A., Carlyle, K. E., & Fuemmeler, B. F. (2021). COVID-19–Related Misinformation among Parents of Patients with Pediatric Cancer. Emerging Infectious Diseases, 27(2), 650CrossRefPubMedPubMedCentral

Hoffman, L., Okcu, M. F., Dreyer, Z. E., Suzawa, H., Bryant, R., & Middleman, A. B. (2012). Human papillomavirus vaccination in female pediatric cancer survivors. Journal of pediatric and adolescent gynecology, 25(5), 305–307CrossRefPubMed

Institute of Medicine and National Research Council. (2006). From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: The National Academies Press

Kaiser Family Foundation (2020). KFF COVID-19 Vaccine Monitor: December 2020. Retrieved from https://www.kff.org/coronavirus-covid-19/report/kff-covid-19-vaccine-monitor-december-2020/

Kaiser Family Foundation (2022). KFF COVID-19 Vaccine MonitorFebruary 2022. Retrieved from https://files.kff.org/attachment/TOPLINE-KFF-COVID-19-Vaccine-Monitor-February-2022.pdf

Kasting, M. L., Head, K. J., Cox, D., Cox, A. D., & Zimet, G. D. (2019). The effects of message framing and healthcare provider recommendation on adult hepatitis B vaccination: A randomized controlled trial. Preventive medicine, 127, 105798CrossRefPubMedPubMedCentral

Kelkar, A. H., Blake, J. A., Cherabuddi, K., Cornett, H., McKee, B. L., & Cogle, C. R. (2021). Vaccine Enthusiasm and Hesitancy in Cancer Patients and the Impact of a Webinar. Healthcare, 9(3), 351CrossRefPubMedPubMedCentral

Kirchhoff, A. C., Mann, K., Warner, E. L., Kaddas, H. K., Fair, D., Fluchel, M., & Kepka, D. (2019). HPV vaccination knowledge, intentions, and practices among caregivers of childhood cancer survivors. Human vaccines & immunotherapeutics, 15(7–8), 1767–1775CrossRef

Klosky, J. L., Gamble, H. L., Spunt, S. L., Randolph, M. E., Green, D. M., & Hudson, M. M. (2009). Human papillomavirus vaccination in survivors of childhood cancer. Cancer: Interdisciplinary International Journal of the American Cancer Society, 115(24), 5627–5636CrossRef

Klosky, J. L., Russell, K. M., Simmons, J. L., Foster, R. H., Peck, K., Green, D. M., & Hudson, M. M. (2015). Medical and sociodemographic factors associated with human papillomavirus (HPV) vaccination adherence among female survivors of childhood cancer. Pediatric blood & cancer, 62(9), 1630–1636CrossRef

Korde, L. A., Best, A. F., Gnjatic, S., Denicoff, A. M., Mishkin, G. E., Bowman, M., & Chanock, S. J. (2021). Initial reporting from the prospective National Cancer Institute (NCI) COVID-19 in Cancer Patients Study (NCCAPS). Journal of Clinical Oncology, 39(15_suppl), 6565–6565CrossRef

Lockyer, B., Islam, S., Rahman, A., Dickerson, J., Pickett, K., Sheldon, T., Wright, J., McEachan, R., Sheard, L. & the Bradford Institute for Health Research Covid-19 Scientific Advisory Group. (2021). Understanding COVID-19 misinformation and vaccine hesitancy in context: Findings from a qualitative study involving citizens in Bradford, UK. Health Expectations, 24(4), 1158–1167

Lu, P., Srivastav, A., Amaya, A., Dever, J. A., Roycroft, J., Kurtz, M. S., & Williams, W. W. (2018). Association of provider recommendation and offer and influenza vaccination among adults aged ≥ 18 years–United States. Vaccine, 36(6), 890–898CrossRefPubMed

MacDonald, N. E., & the SAGE Working Group on Vaccine Hesitancy. (2015). Vaccine hesitancy: Definition, scope and determinants. Vaccine, 33(34), 4161–4164CrossRefPubMed

Mayo, S. J., Ajaj, R., & Drury, A. (2021). SURVIVORS’PREFERENCES FOR THE ORGANIZATION AND DELIVERY OF SUPPORTIVE CARE AFTER TREATMENT: AN INTEGRATIVE REVIEW.European Journal of Oncology Nursing,102040

Monin, L., Laing, A. G., Muñoz-Ruiz, M., McKenzie, D. R., Barrio, D., Alaguthurai, I. D. M., & Seow, T. (2021). J. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. The Lancet Oncology

Nápoles, A. M., Santoyo-Olsson, J., Stewart, A. L., Ortiz, C., Samayoa, C., Torres‐Nguyen, A., & Gonzalez, N. (2020). Nuevo Amanecer‐II: Results of a randomized controlled trial of a community‐based participatory, peer‐delivered stress management intervention for rural Latina breast cancer survivors. Psycho‐Oncology, 29(11), 1802–1814CrossRefPubMedPubMedCentral

National Cancer Institute - Office of Cancer Survivorship (2021). Statistics, Graphs and Definitions. Retrieved from https://cancercontrol.cancer.gov/ocs/statistics

National Comprehensive Cancer Network (2021). Recommendations of the NCCN COVID-19 Vaccination Advisory Committee. Retrieved from https://www.nccn.org/docs/default-source/covid-19/2021_covid-19_vaccination_guidance_v3-0.pdf?sfvrsn=b483da2b_60

Nekhlyudov, L. (2021). How Your Primary Care Provider Can Help You Throughout Your Cancer Experience. Retrieved from https://www.cancer.net/blog/2021-03/how-your-primary-care-provider-can-help-you-throughout-your-cancer-experience

Office of the Surgeon General (2021). Confronting Health Misinformation: The U.S. Surgeon General’s Advisory on Building a Healthy Information Environment. Retrieved from Washington (DC): https://www.hhs.gov/sites/default/files/surgeon-general-misinformation-advisory.pdf

Öster, I., Hedestig, O., Johansson, M., Klingstedt, N., & Lindh, J. (2013). Sharing experiences in a support group: men’s talk during the radiotherapy period for prostate cancer. Palliative & supportive care, 11(4), 331–339CrossRef

Palich, R., Veyri, M., Marot, S., Vozy, A., Gligorov, J., Maingon, P., & Spano, J. P. (2021). Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients.Annals of Oncology

Panozzo, C. A., Head, K. J., Kornides, M. L., Feemster, K. A., & Zimet, G. D. (2020). Tailored messages addressing human papillomavirus vaccination concerns improves behavioral intent among mothers: a randomized controlled trial. Journal of Adolescent Health, 67(2), 253–261CrossRef

Pinto, B. M., Stein, K., & Dunsiger, S. (2015). Peers promoting physical activity among breast cancer survivors: A randomized controlled trial. Health Psychology, 34(5), 463CrossRefPubMed

Potter, D. A., Thomas, A., & Rugo, H. S. (2021). A Neoadjuvant Chemotherapy Trial for Early Breast Cancer is Impacted by COVID-19: Addressing Vaccination and Cancer Trials Through Education, Equity, and Outcomes.Clinical Cancer Research

Rosenthal, S., Weiss, T. W., Zimet, G. D., Ma, L., Good, M., & Vichnin, M. (2011). Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician’s recommendation. Vaccine, 29(5), 890–895CrossRefPubMed

Shelal, Z., Cho, D., Urbauer, D. L., Lu, Q., Ma, B. Y., Rohrer, A. M., & Ramondetta, L. M. (2020). Knowledge matters and empowers: HPV vaccine advocacy among HPV-related cancer survivors. Supportive Care in Cancer, 28(5), 2407–2413CrossRefPubMed

Shourie, S., Jackson, C., Cheater, F. M., Bekker, H. L., Edlin, R., Tubeuf, S., & Bleasby, B. (2013). A cluster randomised controlled trial of a web based decision aid to support parents’ decisions about their child’s Measles Mumps and Rubella (MMR) vaccination. Vaccine, 31(50), 6003–6010CrossRefPubMedPubMedCentral

Tran, V. T., Sidorkiewicz, S., Péan, C., & Ravaud, P. (2021). Impact of an interactive web tool on patients’ intention to receive COVID-19 vaccination: a before-and-after impact study among patients with chronic conditions in France. BMC medical informatics and decision making, 21(1), 1–7CrossRef

Van Bavel, J. J., Baicker, K., Boggio, P. S., Capraro, V., Cichocka, A., Cikara, M., & Druckman, J. N. (2020). Using social and behavioural science to support COVID-19 pandemic response. Nature Human Behaviour, 4(5), 460–471CrossRefPubMed

Verger, P., & Dubé, E. (2020). Restoring confidence in vaccines in the COVID-19 era. In: Taylor & Francis

Viswanath, K., Ramanadhan, S., & Kontos, E. Z. (2007). Mass media. In S. Galea (Ed.), Macrosocial determinants of population health (pp. 275–294). New York, New York: SpringerCrossRef

Wang, Q., Berger, N. A., & Xu, R. (2021). Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection. JAMA oncology, 7(2), 220–227CrossRefPubMed

Warner, E. L., Lopez, V., Kepka, P. L., Mann, D., Kaddas, K., Fair, H. K., & Martel, D., L (2020). Influence of provider recommendations to restart vaccines after childhood cancer on caregiver intention to vaccinate. Journal of Cancer Survivorship, 14, 757–767CrossRefPubMedPubMedCentral

Waters, A. R., Kepka, D., Ramsay, J. M., Mann, K., Lopez, V., Anderson, P. L., & Ray, J. S., N (2021). COVID-19 Vaccine Hesitancy Among Adolescent and Young Adult Cancer Survivors. JNCI cancer spectrum, 5(3), pkab049CrossRefPubMedPubMedCentral

Waters, A. R., Mann, K., Lopez, P. L. V., Kepka, D., Wu, Y. P., & Kirchhoff, A. C. (2021). HPV Vaccine Experiences and Preferences Among Young Adult Cancer Survivors and Caregivers of Childhood Cancer Survivors.Journal of Cancer Education, 1–6

Witteman, H. O., Chipenda Dansokho, S., Exe, N., Dupuis, A., Provencher, T., & Zikmund-Fisher, B. J. (2015). Risk communication, values clarification, and vaccination decisions. Risk Analysis, 35(10), 1801–1819CrossRefPubMed

Woodfield, M. C., Pergam, S. A., & Shah, P. D. (2021). Cocooning against COVID-19: The argument for vaccinating caregivers of patients with cancer.Cancer

World Health Organization (2019). Ten threats to global health in 2019. Retrieved from https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019

Titel: Using Behavioral Science to Address COVID-19 Vaccine Hesitancy Among Cancer Survivors: Communication Strategies and Research Opportunities
Auteurs: Robin C. Vanderpool
Anna Gaysynsky
Wen-Ying Sylvia Chou
Emily S. Tonorezos
Publicatiedatum: 19-03-2022
Uitgeverij: Springer US
Gepubliceerd in: Journal of Behavioral Medicine / Uitgave 1-2/2023
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI: https://doi.org/10.1007/s10865-022-00304-7

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 1-2/2023

Hesitant but vaccinated: assessing COVID-19 vaccine hesitancy among the recently vaccinated

The effects of social-media based social comparison information and similarity mindsets on COVID-19 vaccination uptake cognitions

Reducing COVID-19 vaccine hesitancy among African Americans: the effects of narratives, character’s self-persuasion, and trust in science

Is tailored messaging more effective? An analysis of a digital health intervention to promote HPV vaccination intent among Latinx

The Effect of Science-Related Populism on Vaccination Attitudes and Decisions

HPV vaccine delay and refusal among unvaccinated Mexican American young adult women: a qualitative investigation of Mexican-born and US-born HPV vaccine decision narratives